Adama registró un aumento de 19.1% en las ganancias para 2014 impulsado por más ventas de productos en América Latina, Europa y América del Norte.
Antes de los costos únicos relacionados con la preparación para una oferta pública inicial y la provisión para la jubilación anticipada de los empleados, los ingresos netos del año aumentaron casi 15% a $146 millones, dijo Adama.
La compañía, que es propiedad mayoritaria de CNAC, el brazo de agroquímicos de ChemChina, registró una pérdida neta más amplia de $32.6 millones en el cuarto trimestre, en comparación con una pérdida de $29.1 millones en el mismo período del año anterior. Los ingresos aumentaron 2.8% a $674.2 millones en el período.
Para el año completo, el ingreso neto ajustado aumentó 19.1% a $151.3 millones, de $127.1 millones en 2013. Los ingresos del año completo aumentaron 4.7% a $3.22 mil millones.
Adama Chairman Yang Xingqiang said, “The past year was an exceptional period for Adama as we took a number of steps to position our organization for long-term growth. Most importantly, we laid the groundwork for our expansion into China, a vital and fast-growing market with significant untapped potential.”
Xingqiang said that with investments underway in a global formulation center and R&D hub in China, as well as combining with the China business, “Adama is building the foundation of a leading platform, which will allow the company to fully capitalize on this major growth opportunity.”
Chen Lichtenstein, Adama president and chief executive officer, commented on the company’s new organizational structure unveiled in 2014. “We divided our global commercial operations into seven regional clusters, to enable better support and tighter delivery across our geographies. We also set up a designated division for Innovation, Development, Research and Registration (IDR), which, by managing and coordinating all these activities, will drive and focus our efforts to further increase the differentiation and innovation in our product offering.”
Actualización de la OPI
Citing adverse market conditions, Adama postponed its planned IPO on the New York Stock Exchange in late 2014. “Various possibilities” are being examined regarding executing the business combination between the company and the China business, “whether by consummating the acquisition as originally agreed, or in a different manner.”
The company said it is also considering its options regarding a future flotation, including both the listing venue and its timing, “all in accordance with the advantages of the different markets and the developments in market conditions.”